Compile Data Set for Download or QSAR
Report error Found 49 Enz. Inhib. hit(s) with all data for entry = 50020790
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633609(CHEMBL5426352)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633610(CHEMBL5414256)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633614(CHEMBL5406950)
Affinity DataIC50: 1nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633615(CHEMBL5402470)
Affinity DataIC50: 1nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633618(CHEMBL5437679)
Affinity DataIC50: 2nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633606(CHEMBL5423227)
Affinity DataIC50: 3nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633613(CHEMBL5411976)
Affinity DataIC50: 3nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633616(CHEMBL5424195)
Affinity DataIC50: 3nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633603(CHEMBL5419204)
Affinity DataIC50: 3nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
LigandPNGBDBM50436459(CHEMBL2396661)
Affinity DataIC50: 3nMAssay Description:Inhibition of PI3Kalpha H1047R mutant (unknown origin) using PI(4,5)P2:PS as substrate incubated in presence of ATP by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633617(CHEMBL5408522)
Affinity DataIC50: 3nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
LigandPNGBDBM50436459(CHEMBL2396661)
Affinity DataIC50: 4.60nMAssay Description:Inhibition of wild type PI3Kalpha (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMedPDB3D3D Structure (crystal)
LigandPNGBDBM50436459(CHEMBL2396661)
Affinity DataIC50: 4.80nMAssay Description:Inhibition of PI3Kalpha H1047R mutant (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633625(CHEMBL5406570)
Affinity DataIC50: 9nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633623(CHEMBL5430524)
Affinity DataIC50: 14nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633622(CHEMBL5422741)
Affinity DataIC50: 15nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633621(CHEMBL5424291)
Affinity DataIC50: 18nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633611(CHEMBL5424735)
Affinity DataIC50: 28nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
LigandPNGBDBM50389047(CHEMBL2064328)
Affinity DataIC50: 57nMAssay Description:Inhibition of PI3Kbeta (unknown origin) incubated for 20 mins in presence of gamma-32P-ATP by TLC analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
LigandPNGBDBM50633615(CHEMBL5402470)
Affinity DataIC50: 73nMAssay Description:Inhibition of PI3Kalpha H1047R mutant (unknown origin) using PI(4,5)P2:PS as substrate incubated in presence of ATP by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633605(CHEMBL5436038)
Affinity DataIC50: 78nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633604(CHEMBL5404456)
Affinity DataIC50: 115nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633624(CHEMBL5409207)
Affinity DataIC50: 144nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633607(CHEMBL5440814)
Affinity DataIC50: 179nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633604(CHEMBL5404456)
Affinity DataIC50: 332nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633620(CHEMBL5431134)
Affinity DataIC50: 375nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
LigandPNGBDBM50633605(CHEMBL5436038)
Affinity DataIC50: 411nMAssay Description:Inhibition of PI3Kalpha H1047R mutant (unknown origin) using PI(4,5)P2:PS as substrate incubated in presence of ATP by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
LigandPNGBDBM602718(US11649227, Example 376 | US20230286960, Example 3...)
Affinity DataIC50: 500nMAssay Description:Inhibition of recombinant N-terminal 6-His tagged full length human PI3Kalpha H1047R mutant using PIP2diC8 and PIP2:PS as substrate incubated for 1 h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633614(CHEMBL5406950)
Affinity DataIC50: 567nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633617(CHEMBL5408522)
Affinity DataIC50: 681nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633618(CHEMBL5437679)
Affinity DataIC50: 779nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633619(CHEMBL5413908)
Affinity DataIC50: 1.37E+3nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633606(CHEMBL5423227)
Affinity DataIC50: 1.47E+3nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633616(CHEMBL5424195)
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633608(CHEMBL5401780)
Affinity DataIC50: 2.54E+3nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
LigandPNGBDBM50389047(CHEMBL2064328)
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) incubated for 20 mins in presence of gamma-32P-ATP by TLC analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633603(CHEMBL5419204)
Affinity DataIC50: 3.19E+3nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633610(CHEMBL5414256)
Affinity DataIC50: 4.74E+3nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633605(CHEMBL5436038)
Affinity DataIC50: 5.89E+3nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633611(CHEMBL5424735)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633612(CHEMBL5394975)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633613(CHEMBL5411976)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633615(CHEMBL5402470)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633609(CHEMBL5426352)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633608(CHEMBL5401780)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633607(CHEMBL5440814)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633619(CHEMBL5413908)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633620(CHEMBL5431134)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AKT phosphorylation in human SK-BR-3 cells harboring wildtype PI3Kalpha incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Mirati Therapeutics

Curated by ChEMBL
LigandPNGBDBM50633612(CHEMBL5394975)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AKT phosphorylation in human T47D cells harboring PI3Kalpha H1047R mutant incubated for 24 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed